# Myoptechs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/myoptechs

- Industry: Medical Devices & Equipment
- Headquarters: Columbus, US
- Website: www.myoptechs.com/
- Total disclosed funding: $1.3M
- Latest round: Seed (Aug 30, 2024)
- Investors on record: 2

## About

Based in Ohio, US, and founded in 2022, Myoptechs, Inc. is an ophthalmic medical device company offering eye contact lenses that help patients suffering from myopia slow down their progression. As of 2024, the company is headed by its CEO Paul Grimm. In August 2024, the firm raised USD 1.27 million in Seed funding from investors Rev1 Ventures and WS Investment Company.

The company offers a solution designed to slow the progression of myopia (nearsightedness) while providing clear vision. Myoptechs’ primary offering is a soft contact lens featuring the patent-pending Faceted Optical System™, which is specifically engineered to manage myopia progression. This design aims to provide clearer vision and myopic defocus—an optical signal known to help slow the progression of myopia.

## Funding rounds

- Seed, Aug 30, 2024, $1.3M — WS Investments, Rev1 Ventures

## Investors

- WS Investments (https://capitalatlas.ai/funds/ws-investments) — Seed
- Rev1 Ventures (https://capitalatlas.ai/funds/rev1-ventures) — Seed